The University of Chicago Header Logo

Connection

John Beshai to Angiotensin II Type 1 Receptor Blockers

This is a "connection" page, showing publications John Beshai has written about Angiotensin II Type 1 Receptor Blockers.
  1. Lipid-lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction. Heart Rhythm. 2006 Aug; 3(8):881-6.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.